MedPath

Xiangtan Central Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Study of Active Intervention in High-risk HFpEF Patients

Not Applicable
Not yet recruiting
Conditions
Heart Failure With Preserved Ejection Fraction
Interventions
Other: Targeted intervention based on risk factors
First Posted Date
2024-08-01
Last Posted Date
2024-08-01
Lead Sponsor
Xiangtan Central Hospital
Target Recruit Count
924
Registration Number
NCT06532019

Risk Factors In Heart Failure Patients With Preserved Ejection Fraction

Completed
Conditions
Heart Failure With Preserved Ejection Fraction
First Posted Date
2024-07-05
Last Posted Date
2024-07-08
Lead Sponsor
Xiangtan Central Hospital
Target Recruit Count
9419
Registration Number
NCT06487468

Outcome of Discharged HFmrEF Patients

Completed
Conditions
Heart Failure With Mid Range Ejection Fraction
First Posted Date
2022-02-15
Last Posted Date
2022-02-15
Lead Sponsor
Xiangtan Central Hospital
Target Recruit Count
1693
Registration Number
NCT05240118

B-lines-guided Heart Failure Management in Heart Failure Patients

Active, not recruiting
Conditions
Lung Ultrasound
Heart Failure
Interventions
Diagnostic Test: Lung ultrasound
First Posted Date
2021-09-05
Last Posted Date
2024-06-28
Lead Sponsor
Xiangtan Central Hospital
Target Recruit Count
320
Registration Number
NCT05035459
Locations
🇨🇳

Xiangtan Central Hospital, Xiangtan, Hunan, China

Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)

Phase 4
Recruiting
Conditions
Heart Failure
Anemia
Interventions
Drug: Placebo
First Posted Date
2021-01-13
Last Posted Date
2024-07-01
Lead Sponsor
Xiangtan Central Hospital
Target Recruit Count
1990
Registration Number
NCT04707261
Locations
🇨🇳

Xiangtan Central Hospital, Xiangtan, Hunan, China

© Copyright 2025. All Rights Reserved by MedPath